Refine Results
- Applications and Industries
-
- Content Type
-
Content Type
- Analysis Platform
-
Product
- Language
-
Language
Applied Filters
Research highlight confirming the critical role of metabolic fitness in CAR-NK cells and its importance to achieve superior clinical outcomes in immunotherapy.
- Publication Part Number: 5994-7661EN
- Created: 30 Aug 2024
- 313 KB
This application note introduces a workflow that uses the XF Real-Time ATP rate assay data for identifying metabolic modulator and drug targets.
- Publication Part Number: 5994-5651EN
- Created: 27 Jan 2023
- 2 MB
Learn about a customized workflow to standardize the identification/investigation of mitochondrial toxicity using Agilent Seahorse XF technology.
- Publication Part Number: 5994-4778EN
- Created: 27 Apr 2022
- 3 MB
| Chinese (Simplified) (China) | Complete (PDF) |
|---|
CAR T-cell manufacturing conditions are critical to differentiation, metabolic fitness, and cytotoxic function, enhancing therapy efficacy and production efficiency.
- Publication Part Number: Cyto 2025
- Created: 05 June 2025
- 537 KB
Poster for the annual meeting (2025) of American Association of Immunologists, showing exhausted T cells generated through chronic beads activation have a distinct and consistent metabolic phenotype that can be assess using XF Pro and T Cell...
- Publication Part Number: AAI 2025 #2341
- Created: 14 May 2025
- 602 KB
AACR 2025 poster: Chronic anti-CD3/CD28 stimulation during cell expansion generates exhausted T cells with a distinct metabolic and cytotoxic phenotype
- Publication Part Number: AACR #4856
- Created: 25 Apr 2025
- 475 KB
The poster introduces a multiparametric workflow that allows for evaluating contractility, viability, and metabolic function using validated human iPSC-derived cardiomyocytes to better understand the mechanisms associated with drug-induced...
- Publication Part Number: SOT # 4373
- Created: 24 Mar 2025
- 504 KB
we demonstrated consistent production of CAR T-cells using the functionally closed and automated cell manufacturing Lonza Cocoon platform, using a novelcombination of cell analysis parameters obtained from an Agilent xCELLigence RTCA system, a...
- Publication Part Number: #149
- Created: 17 Mar 2025
- 375 KB
This editorial showcases Agilent solutions for metabolic modulation enhancing CAR T-cell activation, persistence, and serial killing for improved cancer immunotherapy
- Publication Part Number: 5994-7739EN
- Created: 04 Nov 2024
- 830 KB
CAR-TCR 2024 Poster. We demonstrated the successful production of CAR T-cells using the Lonza Cocoon system. Additionally, CAR T-cell in-process analyses and critical process parameters were evaluated using the combination of a flow cytometer, a...
- Created: 18 Sep 2024
- 450 KB
The Agilent Seahorse XF Pro instrument performance specification sheet.
- Publication Part Number: 5994-4264EN
- Created: 07 Apr 2023
- 925 KB
Learn about the principle and parameter calculations in the Agilent Seahorse XF Mito Tox assay solution used to assess mitochondrial toxicity
- Publication Part Number: 5994-4732EN
- Created: 18 Jan 2023
- 2 MB
| Chinese (Simplified) (China) | Complete (PDF) |
|---|
Case study about CAR-T therapy
- Publication Part Number: 5994-4389EN
- Created: 16 Dec 2021
- 477 KB
關(guān)于 CAR-T 療法的案例研究
- Publication Part Number: 5994-4389ZHCN
- Created: 16 Dec 2021
- 194 KB